{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:17:25Z","timestamp":1789507045006,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T00:00:00Z","timestamp":1358812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T00:00:00Z","timestamp":1358812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>The diagnostic, predictive and prognostic role of anti-cyclic citrullinated peptide (CCP) antibodies in rheumatoid arthritis (RA) patients is widely accepted. Moreover, detection of these antibodies in subjects presenting with undifferentiated arthritis (UA) is associated with a significant risk to develop the disease. On the other hand, clinical and prognostic significance of evaluating anti-CCP levels in subjects with inflammatory arthritis at disease onset has not been fully clarified. The goal of this prospective study is to analyze the value and prognostic significance of anti-CCP titer quantification in UA subjects.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Serial anti-CCP assays were measured in 192 consecutive patients presenting with UA lasting less than 12 weeks. Clinical and serological data and arthritis outcome were evaluated every 6 months until two years of follow-up.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Anti-CCP positivity, at both low and high titer, and arthritis of hand joints significantly predicted RA at two years, risk increasing in subjects with high anti-CCP titers at baseline. Moreover, time to RA diagnosis was shorter in patients with high anti-CCP2 titers at enrollment with respect to those with low antibody concentration.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Presence of anti-CCP antibodies, at both low and high concentration, is significantly associated with RA development in subjects with recent onset UA. However, time interval from the onset of the first symptoms to the fulfilment of the classification criteria appears to be directly related to the initial anti-CCP level.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar4148","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T11:41:11Z","timestamp":1358941271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study"],"prefix":"10.1186","volume":"15","author":[{"given":"Nicola","family":"Bizzaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Morozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Manganelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Riccieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Filippini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Tampoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Afeltra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Alpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Bini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onelia","family":"Bistoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Alunno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA Group)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,22]]},"reference":[{"key":"3885_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","volume":"7","author":"W Van Venrooij","year":"2011","unstructured":"Van Venrooij W, van Beers J, Pruijn G: Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol. 2011, 7: 391-398. 10.1038\/nrrheum.2011.76.","journal-title":"Nat Rev Rheumatol"},{"key":"3885_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"147","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S: Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007, 147: 797-808.","journal-title":"Ann Intern Med"},{"key":"3885_CR3","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1373\/clinchem.2007.087569","volume":"53","author":"N Bizzaro","year":"2007","unstructured":"Bizzaro N, Tonutti E, Tozzoli R, Villalta D: Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins. Clin Chem. 2007, 53: 1527-1533. 10.1373\/clinchem.2007.087569.","journal-title":"Clin Chem"},{"key":"3885_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/art.21739","volume":"54","author":"AH van der Helm-van Mil","year":"2006","unstructured":"van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR: The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not and independent risk factor for development of rheumatoid arthritis. Arthritis Rheum. 2006, 54: 1117-1121. 10.1002\/art.21739.","journal-title":"Arthritis Rheum"},{"key":"3885_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.autrev.2012.02.015","volume":"11","author":"E Bartoloni","year":"2012","unstructured":"Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R, on behalf of the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators: Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature. Autoimmun Rev. 2012, 11: 815-820. 10.1016\/j.autrev.2012.02.015.","journal-title":"Autoimmun Rev"},{"key":"3885_CR6","first-page":"815038","volume":"2011","author":"P Taylor","year":"2011","unstructured":"Taylor P, Gartemann J, Hsieh J, Creeden J: A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factors tests for rheumatoid arthritis. Autoimmun Dis. 2011, 2011: 815038-","journal-title":"Autoimmun Dis"},{"key":"3885_CR7","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1002\/art.22868","volume":"56","author":"M Bukhari","year":"2007","unstructured":"Bukhari M, Thomson W, Naseem H, Bunn D, Silman A, Symmons D, Barton A: The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis. Results from the Norfolk Arthritis Register. Arthritis Rheum. 2007, 56: 2929-2935. 10.1002\/art.22868.","journal-title":"Arthritis Rheum"},{"key":"3885_CR8","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J R\u00f6nnelid","year":"2005","unstructured":"R\u00f6nnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF: Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis. 2005, 64: 1744-1749. 10.1136\/ard.2004.033571.","journal-title":"Ann Rheum Dis"},{"key":"3885_CR9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/ard.2007.073718","volume":"67","author":"R Gerli","year":"2008","unstructured":"Gerli R, Bartoloni Bocci E, Sherer Y, Vaudo G, Moscatelli S, Shoenfeld Y: Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 724-725.","journal-title":"Ann Rheum Dis"},{"key":"3885_CR10","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S, de Jong BAW, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ: Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003, 48: 2741-2749. 10.1002\/art.11223.","journal-title":"Arthritis Rheum"},{"key":"3885_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA: Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004, 50: 380-386. 10.1002\/art.20018.","journal-title":"Arthritis Rheum"},{"key":"3885_CR12","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, et al: 2010 Rheumatoid Arthritis Classification Criteria. An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum. 2010, 62: 2569-2581. 10.1002\/art.27584.","journal-title":"Arthritis Rheum"},{"key":"3885_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/art.20044","volume":"50","author":"F van Gaalen","year":"2004","unstructured":"van Gaalen F, Linn-Rasker S, van Venrooij W, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW: Autoantibodies to cyclic citrullinated peptide predict progression to rheumatoid arthritis in patients with undifferentiated arthritis. Arthritis Rheum. 2004, 50: 709-715. 10.1002\/art.20044.","journal-title":"Arthritis Rheum"},{"key":"3885_CR14","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"M Van der Linden","year":"2009","unstructured":"Van der Linden M, ven der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH: Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullanted peptide compared with second generation anti-cyclic citrullinated peptid and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. Arthritis Rheum. 2009, 60: 2232-2241. 10.1002\/art.24716.","journal-title":"Arthritis Rheum"},{"key":"3885_CR15","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/art.22525","volume":"56","author":"H van Dongen","year":"2007","unstructured":"van Dongen H, Van Aken J, Lard L, Visser K, Ronday HK, Hulsmans HM, Speyer I, Westedt ML, Peeters AJ, Allaart CF, Toes RE, Breedveld FC, Huizinga TW: Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2007, 56: 1424-1432. 10.1002\/art.22525.","journal-title":"Arthritis Rheum"},{"key":"3885_CR16","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/ar1896","volume":"8","author":"O Meyer","year":"2006","unstructured":"Meyer O, Nicaise-Roland P, dos Santos M, Labarre C, Dougados M, Goupille P, Cantagrel A, Sibilia J, Combe B: Serial determination of cyclic citrullinated peptide antibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Res Ther. 2006, 8: R40-10.1186\/ar1896.","journal-title":"Arthritis Res Ther"},{"key":"3885_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12016-007-8018-1","volume":"34","author":"N Papadopoulos","year":"2008","unstructured":"Papadopoulos N, Tsiaousis G, Pavlitou-Tsiontsi A, Giannakou A, Galanopoulou V: Does the presence of anti-CCP autoantibodies and titer serum levels influence the severity and activity in rheumatoid arthritis patients?. Clinic Rev Allerg Immunol. 2008, 34: 11-15. 10.1007\/s12016-007-8018-1.","journal-title":"Clinic Rev Allerg Immunol"},{"key":"3885_CR18","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/acr.20288","volume":"62","author":"MC Guzian","year":"2010","unstructured":"Guzian MC, Carrier N, Cossette P, de Brum-Fernandes AJ, Liang P, M\u00e9nard HA, Boire G: Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time and specificity of the autoantibodies. Arthritis Care Res. 2010, 62: 1624-1632. 10.1002\/acr.20288.","journal-title":"Arthritis Care Res"},{"key":"3885_CR19","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3899\/jrheum.110234","volume":"38","author":"MD Mjaavatten","year":"2011","unstructured":"Mjaavatten MD, van der Heijde D, Uhling T, Haugen AJ, Nygaard H, Bj\u00f8rneboe O, Kvien TK: Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of follow-up in recent-onset arthritis? A longitudinal study. J Rheumatol. 2011, 38: 2336-2341. 10.3899\/jrheum.110234.","journal-title":"J Rheumatol"},{"key":"3885_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/rheumatology\/keq190","volume":"50","author":"L Barra","year":"2011","unstructured":"Barra L, Pope J, Bessette L, Haraoui B, Bykerk V: Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review. Rheumatology. 2011, 50: 311-316. 10.1093\/rheumatology\/keq190.","journal-title":"Rheumatology"},{"key":"3885_CR21","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1186\/ar3834","volume":"14","author":"M Burr","year":"2012","unstructured":"Burr M, Viatte S, Bukhari M, Plant D, Symmons DP, Thomson W, Barton A: Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis. Arthritis Res Ther. 2012, 14: R109-10.1186\/ar3834.","journal-title":"Arthritis Res Ther"},{"key":"3885_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.autrev.2011.11.011","volume":"11","author":"C Palazzi","year":"2012","unstructured":"Palazzi C, Buskila D, D'Angelo S, D'Amico E, Olivieri I: Autoantibodies in patients with chronic hepatitis C virus infection: pitfalls for the diagnosis of rheumatic diseases. Autoimmun Rev. 2012, 11: 659-663. 10.1016\/j.autrev.2011.11.011.","journal-title":"Autoimmun Rev"},{"key":"3885_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/rheumatology\/kel237","volume":"46","author":"KP Machold","year":"2007","unstructured":"Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, Uffmann M, Smolen JS: Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology. 2007, 46: 342-349.","journal-title":"Rheumatology"},{"key":"3885_CR24","first-page":"1691","volume":"30","author":"LM Jansen","year":"2003","unstructured":"Jansen LM, van Schaardenburg D, van dH-B, van der Stadt RJ, de Koning MH, Dijkmans BA: The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis. J Rheumatol. 2003, 30: 1691-1695.","journal-title":"J Rheumatol"},{"key":"3885_CR25","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"EJ Kroot","year":"2000","unstructured":"Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van't Hof M, van de Putte LB, van Rijswijk MH, van Venrooij WJ, van Riel PL: The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000, 43: 1831-1835. 10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6.","journal-title":"Arthritis Rheum"},{"key":"3885_CR26","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.3899\/jrheum.090338","volume":"36","author":"P Kakumanu","year":"2009","unstructured":"Kakumanu P, Sobel ES, Narain S, Li Y, Akaogi J, Yamasaki Y, Segal MS, Hahn PC, Chan EK, Reeves WH, Satoh M: Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming\/erosive arthritis. J Rheumatol. 2009, 36: 2682-2690. 10.3899\/jrheum.090338.","journal-title":"J Rheumatol"},{"key":"3885_CR27","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10067-007-0558-5","volume":"26","author":"F Kudo-Tanaka","year":"2007","unstructured":"Kudo-Tanaka F, Ohshima S, Ishii M, Mima T, Matsushita M, Azuma N, Harada Y, Katada Y, Ikeue H, Umeshita-Sasai M, Miyatake K, Saeki Y: Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis. Clin Rheumatol. 2007, 26: 1627-1633. 10.1007\/s10067-007-0558-5.","journal-title":"Clin Rheumatol"},{"key":"3885_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3109\/s10165-010-0286-6","volume":"20","author":"Y Emad","year":"2010","unstructured":"Emad Y, Shehata M, Ragab Y, Saad A, Hamza H, Abou-Zeid A: Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis. Mod Rheumatol. 2010, 20: 358-365. 10.1007\/s10165-010-0286-6.","journal-title":"Mod Rheumatol"},{"key":"3885_CR29","doi-asserted-by":"publisher","first-page":"R76","DOI":"10.1186\/ar2995","volume":"12","author":"MD Mjaavatten","year":"2010","unstructured":"Mjaavatten MD, van der Heijde D, Uhlig T, Haugen AJ, Nygaard H, Sidenvall G, Helgetveit K, Kvien TK: The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis. Arthritis Res Ther. 2010, 12: R76-10.1186\/ar2995.","journal-title":"Arthritis Res Ther"},{"key":"3885_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/ard.2008.105759","volume":"69","author":"WH Bos","year":"2010","unstructured":"Bos WH, Wolbink GJ, Boers M, Tijhuis GJ, de Vries N, van der Horst-Bruinsma IE, Tak PP, van de Stadt RJ, van der Laken CJ, Dijkmans BA, van Schaardenburg D: Arthritis development in arthralgia patients is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis. 2010, 69: 490-494. 10.1136\/ard.2008.105759.","journal-title":"Ann Rheum Dis"},{"key":"3885_CR31","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/ar2907","volume":"12","author":"J Ursum","year":"2010","unstructured":"Ursum J, Bos WH, van Dillen N, Dijkmans BAC, van Schaardenburg D: Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study. Arthritis Res Ther. 2010, 12: R8-10.1186\/ar2907.","journal-title":"Arthritis Res Ther"},{"key":"3885_CR32","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1136\/ard.2008.089953","volume":"67","author":"WH Bos","year":"2008","unstructured":"Bos WH, Ursum J, de Vries N, Bartelds GM, Wolbink GJ, Nurmohamed MT, van der Horst-Bruinsma IE, van de Stadt RJ, Crusius JB, Tak PP, Dijkmans BA, van Schaardenburg D: The role of the shared epitope in arthralgia with anticyclic citrullinated peptide antibodies (anti-CCP) and its effect on anti-CCP levels. Ann Rheum Dis. 2008, 67: 1347-1350.","journal-title":"Ann Rheum Dis"},{"key":"3885_CR33","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1136\/ard.2009.124537","volume":"69","author":"D van der Woude","year":"2010","unstructured":"van der Woude D, Rantap\u00e4\u00e4-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, Drijfhout JW, Huizinga TW, Toes RE, Pruijn GJ: Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis. 2010, 69: 1554-1561. 10.1136\/ard.2009.124537.","journal-title":"Ann Rheum Dis"},{"key":"3885_CR34","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3899\/jrheum.080895","volume":"36","author":"LB Chibnik","year":"2009","unstructured":"Chibnik LB, Mandl LA, Costenbader KH, Schur PH, Karlson EW: Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated pepide antibodies in predicting future rheumatoid arthritis. J Rheumatol. 2009, 36: 706-711. 10.3899\/jrheum.080895.","journal-title":"J Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar4148\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:50:14Z","timestamp":1728384614000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar4148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,2]]}},"alternative-id":["3885"],"URL":"https:\/\/doi.org\/10.1186\/ar4148","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,22]]},"assertion":[{"value":"15 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R16"}}